Daniel Pearson

2.9k citations
11 papers · 2.1k · 6 hit papers · h-index 9

Impact in

Papers in

Daniel Pearson

11 papers receiving 2.0k citations

Daniel Pearson's Hit Papers

Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial 2022 · 282 citations
2820+2+5Years since publication100200300400

Peers

Daniel Pearson
Comparison fields: 5 of 100
  • Internal Medicine 176
  • Infectious Diseases 558
  • Epidemiology 874
  • Applied Microbiology and Biotechnology 45
  • Neurology 335
Replace PK Chan with:
PK Chan China
Fiona Hammonds United Kingdom
Stephanie Bell United Kingdom
John Aeron‐Thomas Australia
Julia Grahamslaw United Kingdom
Joanne Avis United Kingdom
Fionn Bellis United Kingdom
Brian Warren South Africa
Amanda Buck United Kingdom
Natalie Fox Australia
Daniel Pearson relative to PK Chan China PK Chan's profile →
Citations per field
00.5×2×4×5.2×
PK Chan · 1×
Citations per year

Countries citing papers authored by Daniel Pearson

Since Specialization
Citations

This map shows the geographic impact of Daniel Pearson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Pearson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Pearson more than expected).

Fields of papers citing papers by Daniel Pearson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Pearson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Pearson. The network helps show where Daniel Pearson may publish in the future.

Co-authors

The 9 scholars most cited alongside Daniel Pearson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Daniel Pearson Line = papers co-authored together Daniel Pearson links everyone, so they are left out of the graph.

All Works

11 of 11 papers shown
#Work
1
Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Hit paper breakdown →
2021403
2
Imaging features and safety and efficacy of endovascular stroke treatment: a meta-analysis of individual patient-level data
Hit paper breakdown →
2018316
3
Penumbral imaging and functional outcome in patients with anterior circulation ischaemic stroke treated with endovascular thrombectomy versus medical therapy: a meta-analysis of individual patient-level data
Hit paper breakdown →
2018314
4
Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Hit paper breakdown →
2022282
5
Effects of a high-dose 24-h infusion of tranexamic acid on death and thromboembolic events in patients with acute gastrointestinal bleeding (HALT-IT): an international randomised, double-blind, placebo-controlled trial
Hit paper breakdown →
2020271
6
Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Hit paper breakdown →
2021211
7 2017200
8 201044
9 202324
10 19968
11 19971

About Daniel Pearson

Daniel Pearson is a scholar working on Epidemiology, Biochemistry, Experimental and Cognitive Psychology, Psychiatry and Mental health and Pharmacology, having authored 11 papers that have together received 2.1k indexed citations. Recurring topics across this work include Acute Ischemic Stroke Management (4 papers), Psychosomatic Disorders and Their Treatments (1 paper), Child and Adolescent Psychosocial and Emotional Development (1 paper), Asthma and respiratory diseases (1 paper), Fibromyalgia and Chronic Fatigue Syndrome Research (1 paper), SARS-CoV-2 and COVID-19 Research (1 paper), Treatment of Major Depression (1 paper) and Blood transfusion and management (1 paper). The work is most often cited by research in Internal Medicine (176 citations), Infectious Diseases (558 citations), Epidemiology (874 citations), Applied Microbiology and Biotechnology (45 citations) and Neurology (335 citations). Daniel Pearson has collaborated with scholars based in Australia, United Kingdom and Netherlands. Frequent co-authors include Alan M. Wilson, Ricky Mullis, Louis Appleby, Alison J. Wearden, I. W. Campbell, Richard Keith Morriss, John M. Plewes, Stephanie C. Koke and Mary E. Sayler. Their work appears in journals such as The Lancet, The Lancet Neurology, JAMA Neurology, Biological Psychiatry and Thorax.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact